<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2257">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04391829</url>
  </required_header>
  <id_info>
    <org_study_id>COVIDSPERM</org_study_id>
    <nct_id>NCT04391829</nct_id>
  </id_info>
  <brief_title>Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males</brief_title>
  <acronym>COVIDSPERM</acronym>
  <official_title>Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of the study, are to describe detection of SARS-CoV-2 in the semen of COVID-19
      positive patients, the duration of positive semen and to investigate the impact on semen
      quality, thereby providing insights into the early impact on male reproductive function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), a novel coronavirus reported in
      late December 2019 in Wuhan, China, has spread world-wide with over 1,000,000 coronavirus
      disease 2019 (COVID-19) cases reported. New developments in molecular virology and
      immunobiology of SARS-CoV-2, improve our understanding about COVID-19 prevention, management,
      and possible long-term effects. Although viral transmission occurs predominantly through
      respiratory droplets, SARS-CoV-2 has been isolated in blood samples and feces from COVID-19
      patients, raising questions about viral shedding in other bodily fluids, including semen, as
      well as alternative modes of transmission.

      The objectives are to describe detection of SARS-CoV-2 in the semen of COVID-19 positive
      patients, the duration of positive semen and to investigate the impact on semen quality,
      thereby providing insights into the early impact on male reproductive function.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 12, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>detection of SARS-CoV-2 in the semen</measure>
    <time_frame>within 7 days after positive testing for SARS-CoV-2</time_frame>
    <description>detection of SARS-CoV-2 in the semen of men positive for SARS-CoV-2 on nasopharyngeal swab</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>duration of SARS-CoV-2 presence in semen</measure>
    <time_frame>from first positive semen testing until first negative semen testing, upto 15 weeks</time_frame>
    <description>in case of a positive SARS-CoV-2 semen sample, for how long stays the virus present in semen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>semen viscosity</measure>
    <time_frame>from first until last semen analysis, upto 15 weeks</time_frame>
    <description>viscosity of semen will be assessed macroscopically</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>semen volume</measure>
    <time_frame>from first until last semen analysis, upto 15 weeks</time_frame>
    <description>semen volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>semen pH</measure>
    <time_frame>from first until last semen analysis, upto 15 weeks</time_frame>
    <description>semen pH</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm motility</measure>
    <time_frame>from first until last semen analysis, upto 15 weeks</time_frame>
    <description>Sperm motility assesment, according to the WHO guidelines of 2010</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm morphology</measure>
    <time_frame>from first until last semen analysis, upto 15 weeks</time_frame>
    <description>Sperm morphology assesment, according to the WHO guidelines of 2010</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm density</measure>
    <time_frame>from first until last semen analysis, upto 15 weeks</time_frame>
    <description>Sperm density assesment, according to the WHO guidelines of 2010</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>COVID-19</condition>
  <condition>Sars-CoV2</condition>
  <condition>Corona Virus Infection</condition>
  <condition>Semen</condition>
  <arm_group>
    <arm_group_label>SARS-CoV-2 positive men</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Men who are tested positive for SARS-CoV-2 by PCR testing on nasopharyngeal swab.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ejaculated semen sample</intervention_name>
    <description>SARS-CoV-2 positive men will be asked to give an ejaculated semen sample, within the seven days after positive testing. Semen samples will be performed every 7 days, until 2 semen PCR tests are negative.</description>
    <arm_group_label>SARS-CoV-2 positive men</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  PCR on nasopharyngeal swab positive for SARS-CoV-2

          -  Age: ≥ 18y - ≤ 50y

          -  Signed informed consent

          -  When undergoing ART treatment: ICSI treatment

        Exclusion Criteria:

          -  Negative test of SARS-CoV-2 on nasopharyngeal swab sample

          -  History of immunosuppression

          -  Impossibility to deliver a semen sample at UZ Brussel on a weekly base

          -  When undergoing ART treatment: IVF treatment
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael De Brucker, MD PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Brussels</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael De Brucker, MD PHD</last_name>
    <phone>+32494455084</phone>
    <email>michaeldebrucker@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Valerie Uvin, MD</last_name>
    <email>valerieuvin@hotmail.com</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019. JAMA Netw Open. 2020 May 1;3(5):e208292. doi: 10.1001/jamanetworkopen.2020.8292.</citation>
    <PMID>32379329</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 13, 2020</study_first_submitted>
  <study_first_submitted_qc>May 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2020</study_first_posted>
  <last_update_submitted>May 15, 2020</last_update_submitted>
  <last_update_submitted_qc>May 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

